Vildagliptin+ Metformin HCL
The combination of Vildagliptin and Metformin HCL is used for the effective management of type 2 diabetes mellitus. Vildagliptin is a DPP-4 inhibitor that increases insulin secretion and decreases glucagon secretion in response to meals, while Metformin is a biguanide that reduces hepatic glucose production and enhances insulin sensitivity. Together, they provide improved glycemic control.